GHB

  Filter by
 

Section

Publication date

Main subject

Keywords

Displaying 1 - 9 of 9
top 25 drugs emergency presentations in sentinel hospitals
Media library

Infographic: top 25 drugs recorded in emergency presentations in sentinel hospitals in 2017 (left) and frequencies of cocaine and amphetamines presentations (percentage of presentations), aggregated by country (right)

06.06.2019
Publications

European Drug Report 2019: Trends and Developments

06.06.2019

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug...
screenshot
Publications

EU Early Warning System on NPS

23.11.2018

This page describes the work and main outputs of the EU Early Warning System on new psychoactive substances. It includes a description of how the system work, an historical timeline of legislation and substances investigated, and NPS drug profiles.
Publications

European Drug Report 2018: Trends and Developments

07.06.2018

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2018 European Drug...
Publications

Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs

01.06.2002

Since the mid-1990s, GHB – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Some EU countries have reported worries over GHB’s surreptitious use in sexual assaults. Although the extent of this is unknown, the EMCDDA and its risk-assessment...
News
News

EU acts on rising concern over synthetic drugs GHB and ketamine

15.03.2001

The EU today responded to rising concern over the misuse of GHB and ketamine. Since the mid-1990s, these two synthetic substances – widely used in human and veterinary medicine for 30 years – have been surfacing as recreational drugs. Some EU countries have reported worries over GHB’s surreptitious...
Document library
Document library

Report from the Commission to the Council called for by the Joint Action on New Synthetic Drugs (97/396/JAI) concerning GHB /* COM/2000/0737 final */

16.11.2000

Decision of the European Commission following the EMCDDA's risk assessment of GHB.
Events
Events

Meeting on the risk assessment of the new psychoactive substances ketamine and GHB

25.09.2000

The extended Scientific Committee of the EMCDDA met on 25–26 September 2000 to examine the risk assessment by the EMCDDA on ketamine and GHB
Molecular structure of GHB
Media library

Molecular structure of GHB

25.09.2000

Molecular structure of 4-hydroxybutanoic acid (gamma-hydroxybutyric acid, GHB).

Loading